HI
ADMA icon

Harbour Investments’s ADMA Biologics ADMA Stock Holding History

Harbour Investments’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36 Hold
4
– – ﹤0.01% 4594
2025
Q4 		$73 Sell
4
-93
-96% -$1.57K ﹤0.01% 3759
2025
Q3 		$1.42K Sell
97
-35,478
-100% -$608K ﹤0.01% 3350
2025
Q2 		$648K Buy
+35,575
New +$725K 0.02% 678

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Harbour Investments's ADMA Position: Q1 2026 in Review

Harbour Investments held its ADMA Biologics (ADMA) position steady in Q1 2026 at 4 shares worth $36. The position accounts for ﹤0.01% of the portfolio, ranked #4594.

Harbour Investments first reported a position in ADMA in Q2 2025 and has held it in 4 quarters since. The position peaked at $648K in Q2 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Harbour Investments held 4 shares of ADMA Biologics worth $36 as of Q1 2026.
  • Harbour Investments left its ADMA Biologics share count unchanged in Q1 2026.
  • ADMA Biologics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4594 holding.
  • Harbour Investments first reported a position in ADMA Biologics in Q2 2025 and has held it in 4 quarters since.
  • Harbour Investments's ADMA Biologics position peaked at $648K in Q2 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.